Strong results from the other arm of CoreValve's U.S. Pivotal Trial with patients at extreme risk for
standard aortic valve - replacement surgery were reported in October and led to Food and Drug Administration approval for the device in this population.
Not exact matches
The new procedure is FDA approved for patients with symptomatic
aortic stenosis (
valve narrowing) who are considered high - risk for
standard valve replacement surgery.
TAVR was first approved by the U.S. Food and Drug Administration (FDA) in 2011 to treat patients with severe
aortic valve stenosis — a problem that occurs when the
valve in the heart's main artery doesn't open fully and forces the heart to work harder to pump blood — for whom
standard surgical
valve replacement is too risky.
The FDA approved the CoreValve System to treat patients with severe
aortic stenosis who are at high risk for surgery based on groundbreaking research showing the transcatheter heart
valve had superior survival rates at one year when compared to open - heart surgery, the current gold
standard for
aortic valve replacement.
Worldwide, an estimated 300,000 people have severe
aortic stenosis — a faulty
valve in the main artery carrying blood out of the heart — and roughly a third of them are deemed unable to withstand the
standard treatment of open - heart surgery to replace the
valve.
The
standard rating is likely and usually the highest rating you can expect if you have
aortic valve stenosis.
Here's a list of the
standard covered conditions: Cancer Life Threatening Cancer Early Prostate Cancer (Partial) Ductal Breast Cancer (Partial) Superficial Malignant Melanoma (Partial) Benign Brain Tumour Stroke Heart Heart Attack Coronary Artery Bypass Surgery Heart
Valve Replacement
Aortic Surgery Angioplasty (Partial) Multiple Sclerosis Motor Neuron Disease Alzheimer's Disease Parkinson's Disease Aplastic Anemia Loss of -LSB-...]
While it's unlikely to qualify for the top life insurance rate class, «Preferred Best,» with
aortic valve stenosis, you may be able to qualify for an average or «
Standard» rate class with some companies, depending on the severity of your stenosis.